BackgroundCheck.run
Search For

Ellen Marie Leahy, 612425 Montana Pines Ct, Lutz, FL 33549

Known as:
Ellen M Leahy Ellen M Salcines Ellen J Salcines James Leahy
Related to:
Journey Melton 55

Ellen Leahy Phones & Addresses

2425 Montana Pines Ct, Lutz, FL 33549    510-3848463   

Elkins Park, PA   

410 S Matanzas Ave, Tampa, FL 33609   

1185 Camellia Ct, San Leandro, CA 94577    510-4303073   

San Lorenzo, CA   

El Sobrante, CA   

Philadelphia, PA   

410 S Matanzas Ave, Tampa, FL 33609    510-4303073   

Work

Company: Arc electric co inc Address: 385 Oyster Point Blvd Ste 2, South San Francisco, CA 94080 Phones: 650-6340682 Position: Cto Industries: Electrical Work

Education

Degree: Graduate or professional degree
Get Report
Control this profile

Mentions for Ellen Marie Leahy

Ellen Leahy resumes & CV records

Resumes

Ellen Leahy Photo 35

Clinical Trial Liaison, Site Engagement - Scientific Affairs Therapeutic Expertise

Location:
2425 Montana Pines Ct, Lutz, FL 33549
Industry:
Pharmaceuticals
Work:
Pra Health Sciences
Clinical Trial Liaison, Site Engagement - Scientific Affairs Therapeutic Expertise Bristol-Myers Squibb Oct 2016 - Jan 2019
Associate Manager, R and D Contracts and Outsourcing, Global Clinical Operations Bristol-Myers Squibb Nov 2015 - Oct 2016
Clinical Trial Results Reporting Specialist, Clinical Trial Transparency, Global Clinical Operations Bristol-Myers Squibb Mar 2014 - Nov 2015
Medical Editor, Advertising and Marketing Services, Worldwide Commercial Operations Bio-Rad Laboratories Oct 2011 - Nov 2013
Technical Editor, Bio-Rad Life Science Group, Marketing and Communications Department Celera Corporation Oct 1999 - Jan 2006
Project Manager and Staff Scientist Ii Versicor May 1996 - Sep 1999
Senior Scientist and Scientific Project Manager Affymax Dec 1992 - May 1996
Scientist and Senior Scientist
Education:
University of Pennsylvania 1990 - 1992
University of South Florida Apr 1990
University of South Florida 1985 - 1990
Doctorates, Doctor of Philosophy, Chemistry University of South Florida 1981 - Dec 1984
Bachelors, Bachelor of Science, Chemistry University of Pennsylvania
Associates
Skills:
Medical Writing, Pharmaceutical Industry, Biotechnology, Life Sciences, Editing, Publications, Chemistry, Organic Chemistry, Organic Synthesis, Research, Cross Functional Team Leadership, Clinical Trials, Clinical Development, Team Leadership, Lifesciences, Biochemistry, Clinical Trial Analysis, Project Management, Continuous Improvement, Thought Leader Engagement, Infectious Diseases, Drug Development, Contract Management, Drug Discovery, Posters, Good Clinical Practice, Clinical Research, Microsoft Office, Adobe Acrobat Pro, Microsoft Excel, Microsoft Word, Microsoft Powerpoint, Collaborative Problem Solving, Leadership, Customer Service, Bilingual, Scientific Presentation, Scientific Communications, Kol Development, Medical Communications, Cardiovascular Medicine, Pre Clinical Studies, Health Economics Outcomes Research, Kol Management, Kol Identification, Team Development, Advisory Boards, Manuscripts, Abstracts, Meeting Summaries, Ama Style
Languages:
English
Spanish
Ellen Leahy Photo 36

Ellen Leahy

Ellen Leahy Photo 37

Ellen Leahy

Ellen Leahy Photo 38

Ellen Leahy

Location:
United States
Ellen Leahy Photo 39

Ellen Leahy

Location:
United States
Ellen Leahy Photo 40

Managed Care Director At Centre For Health Care

Location:
United States
Industry:
Health, Wellness and Fitness

Publications & IP owners

Us Patents

Factor Viia Inhibitors

US Patent:
2002003, Mar 28, 2002
Filed:
Aug 10, 2001
Appl. No.:
09/927423
Inventors:
Ellen Leahy - San Leandro CA, US
International Classification:
A61K031/41
A61K031/4196
C 07D 4 3/02
US Classification:
514/381000, 548/254000, 548/266200, 514/383000
Abstract:
The present invention provides novel compounds of Formula I: its prodrug forms, or pharmaceutically acceptable salts thereof. The compounds of this invention are inhibitors of Factor Vlla (fVlla), and have utility as anticoagulants for the treatment or prevention of thromboembolic disorders in mammals.

Novel Bicyclic Hydroxamates As Inhibitors Of Histone Deacetylase

US Patent:
2006005, Mar 16, 2006
Filed:
Feb 7, 2003
Appl. No.:
10/503508
Inventors:
Ellen Leahy - San Leandro CA, US
Erik Verner - Foster City CA, US
Assignee:
AXYS PHARMACEUTICALS, INC. - SO. San Francisco CA
International Classification:
C07D 235/04
US Classification:
562622000, 564123000, 548305400
Abstract:
The present invention is directed to certain bicyclic hydroxamate derivatives that are inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed

Alicyclic Peptidomimetics

US Patent:
5550251, Aug 27, 1996
Filed:
Feb 23, 1994
Appl. No.:
8/200320
Inventors:
Ralph Hirschmann - Blue Bell PA
Ellen Leahy - Philadelphia PA
Paul Sprengeler - Philadelphia PA
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
C07D40312
A61K 3141
US Classification:
5483121
Abstract:
Compounds are provided which are crossreactive with peptides such as those bound by G-protein-linked receptors, together with preparative and therapeutic methods therefor. The compounds have the general structure: ##STR1## wherein at least one of R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 4, R. sub. 5 or R. sub. 6 comprises a chemical functional group which causes the compounds to be crossreactive with the peptide of interest.

Peptides And Compounds That Bind To The Il-1 Receptor

US Patent:
5786331, Jul 28, 1998
Filed:
Jun 5, 1995
Appl. No.:
8/465391
Inventors:
Ronald W. Barrett - Sunnyvale CA
Stephen D. Yanofsky - San Mateo CA
David Baldwin - Palo Alto CA
Jeff W. Jacobs - San Mateo CA
Phillipe R. Bovy - Los Altos CA
Ellen M. Leahy - San Leandro CA
Richard S. Pottorf - West Chester OH
Assignee:
Affymax Technologies N.V. - Greenford
Hoechst Marion Roussel, Inc. - Kansas City MO
International Classification:
A61K 3808
A61K 3800
C07K 704
US Classification:
514 15
Abstract:
Peptides that bind to the interleukin-1 type I receptor (IL-1RtI) can be used to assay the amount of IL-1R, or an IL-1R agonist or antagonist, in a sample and comprise a sequence of amino acids selected from the group consisting of (1) WXXXGZ. sub. 1 W where Z. sub. 1 is L, I, A, or Q; (2) XXQZ. sub. 5 YZ. sub. 6 XX where Z. sub. 5 is P or Aze where Aze is azetidine; and Z. sub. 6 is S, A, V, or L; and (3) Z. sub. 23 NZ. sub. 24 SZ. sub. 25 Z. sub. 26 Z. sub. 27 Z. sub. 28 Z. sub. 29 Z. sub. 30 L where Z. sub. 23 is D or Y; Z. sub. 24 is D or S; Z. sub. 25 is S or W; Z. sub. 26 is S or Y; Z. sub. 27 is D or V; Z. sub. 28 is S or W; Z. sub. 29 is F or L; and Z. sub. 30 is D or L; and where each amino acid is indicated by standard one letter abbreviation; and each X can be selected from any one of the 20 genetically coded L-amino acids or the stereoisomeric D-amino acids. Also provided are peptides which bind to the IL-1RtI, which are 11 to 40 amino acids in length, which comprise the core sequence of amino acids: Z. sub. 31 XWZ. sub. 32 Z. sub. 33 Z. sub. 34 Z. sub. 35 Z. sub. 36 QZ. sub. 37 Z. sub. 38 where each letter represents the standard one letter abbreviation for an amino acid or an analog thereof; X is selected from the group of natural or unnatural amino acids; Z. sub.

Peptides And Compounds That Bind To The Il-1 Receptor

US Patent:
5861476, Jan 19, 1999
Filed:
Jun 5, 1995
Appl. No.:
8/464538
Inventors:
Ronald W. Barrett - Sunnyvale CA
Stephen D. Yanofsky - San Mateo CA
David Baldwin - Palo Alto CA
Jeff W. Jacobs - San Mateo CA
Phillipe R. Bovy - Los Altos CA
Ellen M. Leahy - San Leandro CA
Richard S. Pottorf - West Chester OH
Assignee:
Affymax Technologies N.V. - Greenford
Hoechst Marion Roussel, Inc. - Kansas City MO
International Classification:
C07K 704
A61K 3800
A61K 3804
US Classification:
530527
Abstract:
Peptides that bind to the interleukin-1 type I receptor (IL-1RtI) can be used to assay the amount of IL-1R, or an IL-1R agonist or antagonist, in a sample and comprise a sequence of amino acids selected from the group consisting of (1) WXXXGZ. sub. 1 W where Z. sub. 1 is L, I, A, or Q; (2) XXQZ. sub. 5 YZ. sub. 6 XX where Z. sub. 5 is P or Aze where Aze is azetidine; and Z. sub. 6 is S, A, V, or L; and (3) Z. sub. 23 NZ. sub. 24 SZ. sub. 25 Z. sub. 26 Z. sub. 27 Z. sub. 28 Z. sub. 29 Z. sub. 30 L where Z. sub. 23 is D or Y; Z. sub. 24 is D or S; Z. sub. 25 is S or W; Z. sub. 26 is S or Y; Z. sub. 27 is D or V; Z. sub. 28 is S or W; Z. sub. 29 is F or L; and Z. sub. 30 is D or L; and where each amino acid is indicated by standard one letter abbreviation; and each X can be selected from any one of the 20 genetically coded L-amino acids or the stereoisomeric D-amino acids. Also provided are peptides which bind to the IL-1RtI, which are 11 to 40 amino acids in length, which comprise the core sequence of amino acids: Z. sub. 31 XWZ. sub. 32 Z. sub. 33 Z. sub. 34 Z. sub. 35 Z. sub. 36 QZ. sub. 37 Z. sub. 38 where each letter represents the standard one letter abbreviation for an amino acid or an analog thereof; X is selected from the group of natural or unnatural amino acids; Z. sub.

Alicyclic Peptidomimetics

US Patent:
5817879, Oct 6, 1998
Filed:
Aug 26, 1996
Appl. No.:
8/702811
Inventors:
Ralph Hirschmann - Blue Bell PA
Ellen Leahy - Philadelphia PA
Paul Sprengeler - Philadelphia PA
Assignee:
Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
C07C 3516
C07D20912
C07D21306
C07D40108
US Classification:
568333
Abstract:
Compounds are provided which are crossreactive with peptides such as those bound by G-protein-linked receptors, together with preparative and therapeutic methods therefor. The compounds have the general structure: ##STR1## wherein at least one of R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 4, R. sub. 5 or R. sub. 6 comprises a chemical functional group which causes the compounds to be crossreactive with the peptide of interest.

Aromatic Peptidomimetics

US Patent:
5250564, Oct 5, 1993
Filed:
Dec 12, 1991
Appl. No.:
7/806048
Inventors:
Ralph Hirschmann - Blue Bell PA
Ellen Leahy - Philadelphia PA
Paul Sprengeler - Philadelphia PA
Assignee:
Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61K 3140
A61K 31405
C07D20904
US Classification:
514414
Abstract:
Compounds are provided which are crossreactive with peptides such as those bound by G-protein-linked receptors, together with preparative and therapeutic methods therefor. The compounds have the general structure: ##STR1## wherein at least one of R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 4, R. sub. 5 or R. sub. 6 comprises a chemical functional group which causes the compounds to be crossreactive with the peptide of interest.

Possible Relatives

David E Leahy  Dawn M Leahy  Dana D Leahy  Debra A Leahy  Daniel M Leahy  Delfina H Leahy  Denise E Leahy  Ellen M Johnson  Ellen M Johnston  Ellen V White 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.